Titan Bio-Tech [TITANBIO] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison
Titan Bio-Tech
BSE
Loading...
Panacea Biotec
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Titan Bio-Tech wins in 13 metrics, Panacea Biotec wins in 4 metrics, with 0 ties. Titan Bio-Tech appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Titan Bio-Tech | Panacea Biotec | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.96 | 91.93 | Titan Bio-Tech |
| Price-to-Book Ratio | 2.38 | 2.99 | Titan Bio-Tech |
| Debt-to-Equity Ratio | 1.82 | 2.67 | Titan Bio-Tech |
| PEG Ratio | N/A | 0.15 | N/A |
| EV/EBITDA | 14.26 | -92.79 | Panacea Biotec |
| Profit Margin (TTM) | 13.76% | -1.50% | Titan Bio-Tech |
| Operating Margin (TTM) | 10.60% | -26.64% | Titan Bio-Tech |
| EBITDA Margin (TTM) | 10.60% | N/A | N/A |
| Return on Equity | 15.01% | -1.05% | Titan Bio-Tech |
| Return on Assets (TTM) | 8.02% | -3.00% | Titan Bio-Tech |
| Free Cash Flow (TTM) | $106.79M | $-776.80M | Titan Bio-Tech |
| Dividend Yield | 0.47% | N/A | N/A |
| 1-Year Return | -27.01% | 204.85% | Panacea Biotec |
| Price-to-Sales Ratio (TTM) | 2.34 | 4.49 | Titan Bio-Tech |
| Enterprise Value | $3.63B | $24.04B | Panacea Biotec |
| EV/Revenue Ratio | 2.32 | 4.30 | Titan Bio-Tech |
| Gross Profit Margin (TTM) | 57.31% | 60.70% | Panacea Biotec |
| Revenue per Share (TTM) | $189 | $92 | Titan Bio-Tech |
| Earnings per Share (Diluted) | $26.08 | $-1.35 | Titan Bio-Tech |
| Beta (Stock Volatility) | 0.32 | 0.34 | Titan Bio-Tech |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Titan Bio-Tech vs Panacea Biotec Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Titan Bio-Tech | -4.67% | 4.49% | -3.34% | 0.20% | -38.24% | -42.03% |
| Panacea Biotec | -0.28% | 2.01% | 1.32% | -18.83% | 4.32% | -6.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Titan Bio-Tech | -27.01% | 89.08% | 205.28% | 1,425.34% | 1,669.40% | 1,991.49% |
| Panacea Biotec | 204.85% | 215.33% | 148.03% | 191.53% | 120.25% | 89.25% |
Performance & Financial Health Analysis: Titan Bio-Tech vs Panacea Biotec
| Metric | TITANBIO | PANACEABIO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.66B | ₹25.12B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 9,704 | 165,424 |
| 90 Day Avg. Volume | 8,360 | 170,622 |
| Last Close | ₹442.35 | ₹409.45 |
| 52 Week Range | ₹373.65 - ₹1,017.85 | ₹132.99 - ₹581.90 |
| % from 52W High | -56.54% | -29.64% |
| All-Time High | ₹1,017.85 (Oct 21, 2024) | ₹581.90 (Apr 28, 2025) |
| % from All-Time High | -56.54% | -29.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | -0.03% |
| Quarterly Earnings Growth | -0.19% | 0.03% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | -0.02% |
| Operating Margin (TTM) | 0.11% | -0.27% |
| Return on Equity (TTM) | 0.15% | -0.01% |
| Debt to Equity (MRQ) | 1.82 | 2.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹185.75 | ₹136.92 |
| Cash per Share (MRQ) | ₹6.73 | ₹18.06 |
| Operating Cash Flow (TTM) | ₹201.23M | ₹-273,700,000 |
| Levered Free Cash Flow (TTM) | ₹67.81M | ₹-1,038,929,984 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.47% | N/A |
| Last 12-Month Dividend | ₹2.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Titan Bio-Tech vs Panacea Biotec
| Metric | TITANBIO | PANACEABIO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.96 | 91.93 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | 0.15 |
| Price to Sales (TTM) | 2.34 | 4.49 |
| Price to Book (MRQ) | 2.38 | 2.99 |
| Market Capitalization | ||
| Market Capitalization | ₹3.66B | ₹25.12B |
| Enterprise Value | ₹3.63B | ₹24.04B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.32 | 4.30 |
| Enterprise to EBITDA | 14.26 | -92.79 |
| Risk & Other Metrics | ||
| Beta | 0.32 | 0.34 |
| Book Value per Share (MRQ) | ₹185.75 | ₹136.92 |
Financial Statements Comparison: Titan Bio-Tech vs Panacea Biotec
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TITANBIO | PANACEABIO |
|---|---|---|
| Revenue/Sales | ₹351.69M | ₹1.33B |
| Cost of Goods Sold | ₹150.13M | ₹520.80M |
| Gross Profit | ₹201.57M | ₹804.50M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹37.27M | ₹-353.00M |
| EBITDA | ₹59.51M | ₹-182.90M |
| Pre-Tax Income | ₹50.29M | ₹-400,000 |
| Income Tax | ₹12.62M | ₹19.50M |
| Net Income (Profit) | ₹40.47M | ₹-19.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TITANBIO | PANACEABIO |
|---|---|---|
| Cash & Equivalents | ₹51.28M | ₹821.30M |
| Total Current Assets | ₹790.38M | ₹5.45B |
| Total Current Liabilities | ₹177.36M | ₹3.67B |
| Long-Term Debt | ₹4.19M | ₹222.10M |
| Total Shareholders Equity | ₹1.53B | ₹8.31B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹571.62M | ₹5.43B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TITANBIO | PANACEABIO |
|---|---|---|
| Operating Cash Flow | ₹45.62M | N/A |
| Capital Expenditures | ₹-33.58M | N/A |
| Free Cash Flow | ₹12.24M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TITANBIO | PANACEABIO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 9,704 | 165,424 |
| Average Daily Volume (90 Day) | 8,360 | 170,622 |
| Shares Outstanding | 8.26M | 61.25M |
| Float Shares | 2.64M | 15.34M |
| % Held by Insiders | 0.67% | 0.73% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Titan Bio-Tech vs Panacea Biotec
| Metric | TITANBIO | PANACEABIO |
|---|---|---|
| Last 12-Month Dividend | ₹2.00 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.47% | N/A |
| 3-Year Avg Annual Dividend | ₹1.77 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.45% | N/A |
| 3-Year Total Dividends | ₹5.30 | ₹0.00 |
| Ex-Dividend Date | Sep 23, 2024 | N/A |